PRESERVING DIGNITY OF LIFE
Home
Patients
Health care professionals
Product - DigniCap™
Treatment
Technical Support
Clinical Evidence
References
Resources
Order information
Dignitana AB

Dignitana´s  share is not as yet listed at any stock exchange but the company is public with roughly 450 shareholders with the aim to introduce the company at the best suitable time point. Contact CEO Martin Waleij (martin.waleij@dignitana.com) for financial information, investment opportunities and share holder questions.
Dignitana AB, Box 24 022, SE-224 21 Lund Sweden | Phone + 46 (0)46 - 163090 | Fax +46(46)163099|Epost info@dignitana.se